Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vascular Biogenics Ltd. (VBLT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-16Dec-31-15Dec-31-14
   10-K10-K20-F20-F20-F20-F20-F20-F
Revenues  0.70.80.90.60.632.629.729.6
            Revenue growth  -14.3%-16.7%64.1%-3.9% 9.4%0.6%-7.4%
Cost of goods sold  0.10.40.40.20.30.00.00.0
Gross profit  0.60.40.50.30.332.629.729.6
            Gross margin  84.2%52.5%57.3%60.5%56.4%100.0%100.0%100.0%
Selling, general and administrative   [+]11.87.75.45.76.43.83.73.8
Research and development  22.923.221.117.415.212.411.211.0
Other operating expenses  -1.2-0.5-1.4-2.7-42.5   
EBITDA   [+]-31.8-28.7-23.3-18.922.416.415.014.9
            EBITDA margin  -4832.1%-3742.2%-2525.9%-3356.4%3829.2%50.4%50.4%50.5%
Depreciation and amortization  1.11.31.21.21.20.10.10.1
EBIT   [+]-32.9-30.0-24.5-20.121.216.314.914.8
            EBIT margin  -4992.9%-3905.7%-2655.4%-3573.3%3631.6%50.0%50.0%50.0%
Interest income, net   [+]0.50.10.30.7-0.2   
Other income (expense), net  64.659.848.538.8-0.6-16.3-14.9-14.8
Pre-tax income  32.329.924.219.420.50.00.00.0
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%   
Net income  32.329.924.219.420.50.00.00.0
            Net margin  4909.4%3895.8%2627.4%3451.2%3503.6%0.0%0.0%0.0%
   
Basic EPS   [+]$0.42$0.45$0.55$0.54$0.62   
Diluted EPS   [+]$0.42$0.45$0.55$0.54$0.62   
   
Shares outstanding (basic)   [+]77.666.343.735.933.0   
Shares outstanding (diluted)   [+]77.666.343.735.933.0   
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy